Häge, A., Banaschewski, T., Buitelaar, J. K., Dijkhuizen, R. M., Franke, B., Lythgoe, D. J., . . . Consortium, T. (2016). Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial. Trials, 17, 141. https://doi.org/10.1186/s13063-016-1266-8
Chicago Style (17th ed.) CitationHäge, Alexander, et al. "Glutamatergic Medication in the Treatment of Obsessive Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD) - Study Protocol for a Randomised Controlled Trial." Trials 17 (2016): 141. https://doi.org/10.1186/s13063-016-1266-8.
MLA (9th ed.) CitationHäge, Alexander, et al. "Glutamatergic Medication in the Treatment of Obsessive Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD) - Study Protocol for a Randomised Controlled Trial." Trials, vol. 17, 2016, p. 141, https://doi.org/10.1186/s13063-016-1266-8.